Lake Street Maintains Buy on MDxHealth, Lowers Price Target to $5

Benzinga Newsdesk www.benzinga.com Negative 66.3%

Neg 66.3% Neu 0% Pos 0%

Lake Street analyst Thomas Flaten maintains MDxHealth (NASDAQ:MDXH) with a Buy and lowers the price target from $9 to $5.